INBP
Integrated BioPharma, Inc.0.3100
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
9.63MP/E (TTM)
15.50Basic EPS (TTM)
0.02Dividend Yield
0%Recent Filings
8-K
Annual meeting results
Integrated BioPharma stockholders overwhelmingly elected Eric Friedman as Class III director for a three-year term at the December 1, 2025 annual meeting, with 20.7 million for and just 183K withheld. They backed a three-year frequency for say-on-pay votes (20.4M for) and approved exec comp (20.8M for). Auditors CBIZ CPAs ratified. Continuity locked in.
8-K
Q3 revenue drops 6.6%
10-Q
Q1 FY2026 results
Integrated BioPharma's Q1 FY2026 sales dipped 6.8% y/y to $12.7M, yet gross profit held at $1.0M (8.0% margin) while operating income fell to $163K from $490K, mainly from lower Contract Manufacturing volumes to key clients Herbalife and Life Extension (91% of segment sales). Cash swelled to $4.7M after $1.3M operating cash flow (up from $657K y/y), less $173K capex; free cash flow generated $1.1M (derived). No debt drawn on $4M PNC revolver due April 2026. Diluted EPS matched $0.00 on 31.4M shares. Solid liquidity covers needs. Customer concentration tempts fate.
8-K
10-K
IPO
Website
Employees
Sector
Industry
BDPT
Bioadaptives, Inc.
0.03+0.00
BFNH
BioForce Nanosciences Holdings,
0.60+0.07
BHST
BioHarvest Sciences Inc.
5.50+0.30
BIOE
Bio Essence Corp.
0.05+0.00
GLUC
Glucose Health, Inc.
0.14+0.00
IGPK
Integrated Cannabis Solutions,
0.00+0.00
INGR
Ingredion Incorporated
112.24-0.55
NAII
Natural Alternatives Internatio
3.19-0.01
NATR
Nature's Sunshine Products, Inc
22.38-0.85
NPRFF
NEPRA FOODS INC.
0.10+0.00